Results 1 - 10 of 27 for eculizumab
  1. Eculizumab injection is used to treat paroxysmal nocturnal hemoglobinuria (PNH: a type of anemia in which too ... bring oxygen to all parts of the body). Eculizumab injection is also used to treat atypical hemolytic ...
  2. Neuromyelitis Optica From the National Institutes of Health (National Institute of Neurological Disorders and Stroke)  
    Multiple Sclerosis/Related Issues ... Multiple Sclerosis ... Optic Nerve Disorders/Specifics ... Optic Nerve Disorders ... Autoimmune Diseases/Specifics ... Autoimmune Diseases
  3. Travelers' Health: Immunocompromised Travelers (Centers for Disease Control and Prevention)  
    Immune System and Disorders/Related Issues ... Immune System and Disorders ... Traveler's Health/Related Issues ... Traveler's Health ... Centers for Disease Control and ...
  4. Hemolytic Anemia From the National Institutes of Health (National Heart, Lung, and Blood Institute)  
    Anemia/Specifics ... Anemia ... National Heart, Lung, and Blood Institute ... From the National Institutes of Health ... Learn more about the causes, symptoms, complications, ...
  5. Safety Information for Meningococcal Vaccines (Centers for Disease Control and Prevention)  
    The latest safety information from CDC on meningococcal vaccines: safety studies, common side effects, vaccines schedules, vaccine package inserts, and ...
  6. Travelers' Health: Meningococcal Disease (Centers for Disease Control and Prevention)  
    Meningitis/Related Issues ... Meningitis ... Meningococcal Infections/Related Issues ... Meningococcal Infections ... Centers for Disease Control and Prevention ... Information ...
  7. ... be needed to prevent clots from forming. Soliris (eculizumab) is a drug used to treat PNH. It ...
  8. ... effective in most people. Sometimes IVIG, rituximab or eculizumab is also used for severe cases. POSITIVE TEST ...
  9. ... someone with meningococcal meningitis, complement deficiency, use of eculizumab, and exposure to cigarette smoking.
  10. ... of drug called a "complement inhibitor," such as eculizumab (also called "Soliris"®) or ravulizumab (also called "Ultomiris"®) ...
previous · 1 · 2 · 3 · next